Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MRM Health NVStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | BE | 27 Jul 2022 | |
Diabetes Mellitus, Type 2 | Preclinical | BE | MRM Health NVStartup | 27 Jul 2022 |
Nonalcoholic Steatohepatitis | Preclinical | BE | MRM Health NVStartup | 27 Jul 2022 |
Nonalcoholic Steatohepatitis | Preclinical | BE | 27 Jul 2022 |